Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Vaccines
|
January 22, 2022
Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution
Supattra Rungmaitree, Charin Thepthai, Zheng Quan Toh, et al.
Journal of the International AIDS Society
|
July 7, 2020
Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study
Tavitiya Sudjaritruk, Sirinya Teeraananchai, Azar Kariminia, et al.
Clinical and Vaccine Immunology : CVI
|
May 24, 2013
Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study
Mona Al-Dabbagh, Keswadee Lapphra, David W Scheifele, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 23, 2024
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever
Junjie Ding, Dumrong Mairiang, Dararat Prayongkul, et al.
The Lancet. Infectious Diseases
|
October 26, 2017
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial
Sirintip Sricharoenchai, Chukiat Sirivichayakul, Kulkanya Chokephaibulkit, et al.
Human Vaccines & Immunotherapeutics
|
July 13, 2023
Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
Chenchit Chayachinda, Kanokwaroon Watananirun, Chayawat Phatihattakorn, et al.
Vaccine
|
February 25, 2021
Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study
Ui Yoon Choi, Ki Hwan Kim, Jin Lee, et al.
Vaccine
|
December 7, 2023
Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines
Kulkanya Chokephaibulkit, Thanyawee Puthanakit, Surasith Chaithongwongwatthana, et al.
Vaccine
|
June 17, 2023
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women
Thanyawee Puthanakit, Kulkanya Chokephaibulkit, Surasith Chaithongwongwatthana, et al.
Vaccine
|
November 18, 2021
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age
Kulkanya Chokephaibulkit, Thanyawee Puthanakit, Niranjan Bhat, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Vaccines
|
January 22, 2022
Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution
Supattra Rungmaitree, Charin Thepthai, Zheng Quan Toh, et al.
Journal of the International AIDS Society
|
July 7, 2020
Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study
Tavitiya Sudjaritruk, Sirinya Teeraananchai, Azar Kariminia, et al.
Clinical and Vaccine Immunology : CVI
|
May 24, 2013
Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study
Mona Al-Dabbagh, Keswadee Lapphra, David W Scheifele, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 23, 2024
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever
Junjie Ding, Dumrong Mairiang, Dararat Prayongkul, et al.
The Lancet. Infectious Diseases
|
October 26, 2017
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial
Sirintip Sricharoenchai, Chukiat Sirivichayakul, Kulkanya Chokephaibulkit, et al.
Human Vaccines & Immunotherapeutics
|
July 13, 2023
Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
Chenchit Chayachinda, Kanokwaroon Watananirun, Chayawat Phatihattakorn, et al.
Vaccine
|
February 25, 2021
Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study
Ui Yoon Choi, Ki Hwan Kim, Jin Lee, et al.
Vaccine
|
December 7, 2023
Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines
Kulkanya Chokephaibulkit, Thanyawee Puthanakit, Surasith Chaithongwongwatthana, et al.
Vaccine
|
June 17, 2023
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women
Thanyawee Puthanakit, Kulkanya Chokephaibulkit, Surasith Chaithongwongwatthana, et al.
Vaccine
|
November 18, 2021
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age
Kulkanya Chokephaibulkit, Thanyawee Puthanakit, Niranjan Bhat, et al.
Page
of 6